Jong Min Park1,2,3,4, Kyung Hwan Shin5,6,7,8, Jung-In Kim1,2,3, So-Yeon Park1,2,3, Seung Hyuck Jeon1, Noorie Choi9, Jin Ho Kim1,2,3, Hong-Gyun Wu1,2,3,9. 1. Department of Radiation Oncology, Seoul National University Hospital, Seoul, Korea (Republic of). 2. Biomedical Research Institute, Seoul National University Hospital, Seoul, Korea (Republic of). 3. Institute of Radiation Medicine, Seoul National University Medical Research Center, Seoul, Korea (Republic of). 4. Robotics Research Laboratory for Extreme Environments, Advanced Institutes of Convergence Technology, Suwon, Korea (Republic of). 5. Department of Radiation Oncology, Seoul National University Hospital, Seoul, Korea (Republic of). radiat@snu.ac.kr. 6. Biomedical Research Institute, Seoul National University Hospital, Seoul, Korea (Republic of). radiat@snu.ac.kr. 7. Institute of Radiation Medicine, Seoul National University Medical Research Center, Seoul, Korea (Republic of). radiat@snu.ac.kr. 8. Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Korea (Republic of). radiat@snu.ac.kr. 9. Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Korea (Republic of).
Abstract
PURPOSE: To investigate and to prevent irradiation outside the treatment field caused by an electron stream in the air generated by the magnetic field during magnetic resonance image-guided accelerated partial breast irradiation (APBI). MATERIALS AND METHODS: In all, 20 patients who received APBI with a magnetic resonance image-guided radiation therapy (MR-IGRT) system were prospectively studied. The prescription dose was 38.5 Gy in 10 fractions of 3.85 Gy and delivered with a tri-cobalt system (the ViewRay system). For each patient, primary plans were delivered for the first five fractions and modified plans with different gantry angles from those of the primary plan (in-treatment plans) were delivered for the remaining five fractions to reduce the skin dose. A 1 cm thick bolus was placed in front of the patient's jaw, ipsilateral shoulder, and arm to shield them from the electron stream. Radiochromic EBT3 films were attached to the front (towards the breast) and back (towards the head) of the bolus during treatment. Correlations between the measured values and the tumor locations, treatment times, and tumor sizes were investigated. RESULTS: For a single fraction delivery, the average areas of the measured isodoses of 14% (0.54 Gy), 12% (0.46 Gy), and 10% (0.39 Gy) at the front of the boluses were as large as 3, 10.4, and 21.4 cm2, respectively, whereas no significant dose could be measured at the back of the boluses. Statistically significant but weak correlations were observed between the measured values and the treatment times. CONCLUSION: During radiotherapy for breast cancer with an MR-IGRT system, the patient must be shielded from electron streams in the air generated by the interaction of the magnetic field with the beams of the three-cobalt treatment unit to avoid unwanted irradiation of the skin outside the treatment field.
PURPOSE: To investigate and to prevent irradiation outside the treatment field caused by an electron stream in the air generated by the magnetic field during magnetic resonance image-guided accelerated partial breast irradiation (APBI). MATERIALS AND METHODS: In all, 20 patients who received APBI with a magnetic resonance image-guided radiation therapy (MR-IGRT) system were prospectively studied. The prescription dose was 38.5 Gy in 10 fractions of 3.85 Gy and delivered with a tri-cobalt system (the ViewRay system). For each patient, primary plans were delivered for the first five fractions and modified plans with different gantry angles from those of the primary plan (in-treatment plans) were delivered for the remaining five fractions to reduce the skin dose. A 1 cm thick bolus was placed in front of the patient's jaw, ipsilateral shoulder, and arm to shield them from the electron stream. Radiochromic EBT3 films were attached to the front (towards the breast) and back (towards the head) of the bolus during treatment. Correlations between the measured values and the tumor locations, treatment times, and tumor sizes were investigated. RESULTS: For a single fraction delivery, the average areas of the measured isodoses of 14% (0.54 Gy), 12% (0.46 Gy), and 10% (0.39 Gy) at the front of the boluses were as large as 3, 10.4, and 21.4 cm2, respectively, whereas no significant dose could be measured at the back of the boluses. Statistically significant but weak correlations were observed between the measured values and the treatment times. CONCLUSION: During radiotherapy for breast cancer with an MR-IGRT system, the patient must be shielded from electron streams in the air generated by the interaction of the magnetic field with the beams of the three-cobalt treatment unit to avoid unwanted irradiation of the skin outside the treatment field.
Entities:
Keywords:
Magnetic field; Magnetic resonance image-guided radiation therapy; Organs at risk; Out-of-field exposure; Radiation protection
Authors: Catherine K Park; Jakub Pritz; Geoffrey G Zhang; Kenneth M Forster; Eleanor E R Harris Journal: Int J Radiat Oncol Biol Phys Date: 2012-03-01 Impact factor: 7.038
Authors: H Omar Wooten; Vivian Rodriguez; Olga Green; Rojano Kashani; Lakshmi Santanam; Kari Tanderup; Sasa Mutic; H Harold Li Journal: Radiother Oncol Date: 2015-03-04 Impact factor: 6.280
Authors: H Omar Wooten; Olga Green; Min Yang; Todd DeWees; Rojano Kashani; Jeff Olsen; Jeff Michalski; Deshan Yang; Kari Tanderup; Yanle Hu; H Harold Li; Sasa Mutic Journal: Int J Radiat Oncol Biol Phys Date: 2015-03-17 Impact factor: 7.038
Authors: Csaba Polgár; Erik Van Limbergen; Richard Pötter; György Kovács; Alfredo Polo; Jaroslaw Lyczek; Guido Hildebrandt; Peter Niehoff; Jose Luis Guinot; Ferran Guedea; Bengt Johansson; Oliver J Ott; Tibor Major; Vratislav Strnad Journal: Radiother Oncol Date: 2010-02-22 Impact factor: 6.280
Authors: Candace Correa; Eleanor E Harris; Maria Cristina Leonardi; Benjamin D Smith; Alphonse G Taghian; Alastair M Thompson; Julia White; Jay R Harris Journal: Pract Radiat Oncol Date: 2016-09-17
Authors: Benjamin D Smith; Douglas W Arthur; Thomas A Buchholz; Bruce G Haffty; Carol A Hahn; Patricia H Hardenbergh; Thomas B Julian; Lawrence B Marks; Dorin A Todor; Frank A Vicini; Timothy J Whelan; Julia White; Jennifer Y Wo; Jay R Harris Journal: Int J Radiat Oncol Biol Phys Date: 2009-07-15 Impact factor: 7.038
Authors: William A Hall; Eric S Paulson; Uulke A van der Heide; Clifton D Fuller; B W Raaymakers; Jan J W Lagendijk; X Allen Li; David A Jaffray; Laura A Dawson; Beth Erickson; Marcel Verheij; Kevin J Harrington; Arjun Sahgal; Percy Lee; Parag J Parikh; Michael F Bassetti; Clifford G Robinson; Bruce D Minsky; Ananya Choudhury; Robert J H A Tersteeg; Christopher J Schultz Journal: Eur J Cancer Date: 2019-10-12 Impact factor: 9.162
Authors: Brian Ng-Cheng-Hin; Christopher Nutting; Kate Newbold; Shreerang Bhide; Dualta McQuaid; Alex Dunlop; Kevin Harrington; Kee Howe Wong Journal: Br J Radiol Date: 2020-05-21 Impact factor: 3.039
Authors: C De-Colle; M Nachbar; D Mӧnnich; S Boeke; C Gani; N Weidner; V Heinrich; J Winter; S Tsitsekidis; O Dohm; D Zips; D Thorwarth Journal: Clin Transl Radiat Oncol Date: 2021-01-22
Authors: Maureen L Groot Koerkamp; Jeanine E Vasmel; Nicola S Russell; Simona F Shaitelman; Carmel N Anandadas; Adam Currey; Danny Vesprini; Brian M Keller; Chiara De-Colle; Kathy Han; Lior Z Braunstein; Faisal Mahmood; Ebbe L Lorenzen; Marielle E P Philippens; Helena M Verkooijen; Jan J W Lagendijk; Antonetta C Houweling; H J G Desiree van den Bongard; Anna M Kirby Journal: Front Oncol Date: 2020-07-28 Impact factor: 6.244
Authors: Victor N Malkov; Sara L Hackett; Bram van Asselen; Bas W Raaymakers; Jochem W H Wolthaus Journal: Med Phys Date: 2019-02-14 Impact factor: 4.071